The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts

被引:66
作者
Shin, Young Hee [1 ]
Min, Jeong Jin [1 ]
Lee, Jong-Hwan [1 ]
Kim, Eun-Hee [1 ]
Kim, Go Eun [1 ]
Kim, Myung Hee [1 ]
Lee, Jeong Jin [1 ]
Ahn, Hyun Joo [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, 50 Irwon Dong, Seoul 06351, South Korea
关键词
Fluvastatin; Insulin; Diabetic cardiomyopathy; Angiotensin-converting enzyme-2; VENTRICULAR DIASTOLIC DYSFUNCTION; DOPPLER-ECHOCARDIOGRAPHY; CARDIOVASCULAR-DISEASE; CARDIOMYOPATHY; ACE2; INSULIN; ROSUVASTATIN; ASSOCIATION; ACTIVATION; MELLITUS;
D O I
10.1007/s00380-016-0936-5
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Independently of the lipid-lowering effects, statin has been reported to attenuate the development of diabetic cardiomyopathy. However, the effect of statin in glucose-controlled diabetic condition has not been demonstrated. We evaluated the effect of fluvastatin on cardiac function, fibrosis, and angiotensin-converting enzyme-2 (ACE2) expression in glucose-controlled diabetic rats. Male Wistar rats were randomly divided into four groups: control (Group C), diabetes (Group D), diabetes with insulin (Group I), and diabetes with insulin and fluvastatin (Group I+ F). Diabetes was induced by a single injection of streptozotocin (65 mg/kg). After 8 weeks, the hearts were extracted following echocardiographic evaluation. Cardiac fibrosis was analyzed using Masson's trichrome stain. Collagens I and III and ACE2 expressions were evaluated by immunohistochemistry and western blot. Group D showed reduced cardiac systolic function compared to the other groups (all P < 0.05). However, diastolic function estimated by E/A ratio was significantly decreased in groups D and I (median: 0.88 and 1.45, respectively) compared to groups C and I+ F (2.97 and 2.15) (all P < 0.05). Cardiac fibrosis was more severe in groups D and I than in groups C and I+ F (all P < 0.05) on Masson's trichrome stain. On immunohistochemistry, ACE2 expression was significantly decreased only in group D (all P < 0.05). However, collagen I and III showed higher expressions in group D compared to groups C and I+ F while no significant difference was observed compared with group I (all P < 0.05). On western blot, collagen I and ACE2 expressions in group D (median: 1.78 and 0.35, respectively) were significantly different from groups C (references: 1) and I+ F (0.76 and 1.21) (all P < 0.05), but not from group I (1.19 and 0.92). Our study suggested a combination of fluvastatin and insulin would be more effective than insulin alone in diabetic hearts. However, the exact mechanism remains to be elucidated.
引用
收藏
页码:618 / 627
页数:10
相关论文
共 42 条
[1]
Role of microangiopathy in diabetic cardiomyopathy [J].
Adameova, Adriana ;
Dhalla, Naranjan S. .
HEART FAILURE REVIEWS, 2014, 19 (01) :25-33
[2]
Aguilar Cristian, 2011, Rev. perú. med. exp. salud publica, V28, P264, DOI 10.1590/s1726-46342011000200013
[3]
Cardiovascular Disease and Risk Management [J].
不详 .
DIABETES CARE, 2015, 38 :S49-S57
[4]
Diabetic cardiomyopathy: role of the E3 ubiquitin ligase [J].
Bai, Tao ;
Wang, Fan ;
Mellen, Nicholas ;
Zheng, Yang ;
Cai, Lu .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 310 (07) :E473-E483
[5]
Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes [J].
Bambace, Clara ;
Sepe, Anna ;
Zoico, Elena ;
Telesca, Mariassunta ;
Olioso, Debora ;
Venturi, Sara ;
Rossi, Andrea ;
Corzato, Francesca ;
Faccioli, Silvia ;
Cominacini, Luciano ;
Santini, Francesco ;
Zamboni, Mauro .
HEART AND VESSELS, 2014, 29 (01) :42-48
[6]
Diabetic cardiomyopathy [J].
Bell, DSH .
DIABETES CARE, 2003, 26 (10) :2949-2951
[7]
The sweeter side of ACE2: Physiological evidence for a role in diabetes [J].
Bindom, Sharell M. ;
Lazartigues, Eric .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 302 (02) :193-202
[8]
Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging [J].
Bonito, P ;
Moio, N ;
Cavuto, L ;
Covino, G ;
Murena, E ;
Scilla, C ;
Turco, S ;
Capaldo, B ;
Sibilio, G .
DIABETIC MEDICINE, 2005, 22 (12) :1720-1725
[9]
Statins for Primary Prevention of Cardiovascular and Cerebrovascular Events in Diabetic Patients without Established Cardiovascular Diseases: A Meta-Analysis [J].
Chen, Y. -H. ;
Feng, B. ;
Chen, Z. -W. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (02) :116-120
[10]
Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? [J].
Cosson, S ;
Kevorkian, JP .
DIABETES & METABOLISM, 2003, 29 (05) :455-466